Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


HTRF® Transcreener® ADP

Product Image
Product Description

Based on HTRF technology, the HTRF Transcreener ADP assay is a universal method for identifying and characterizing the phosphotransferase activity induced by any ATP/ADP dependent target, such as serine/threonine and tyrosine kinases, as well as lipid kinases and chaperonins.

The formation of ADP is detected by a specific monoclonal antibody labeled with Eu3+ cryptate, and directly correlates with the amount of phosphorylated substrate in kinase assays.

Features
•    Monoclonal antibody specific to ADP
•    Homogeneous non-radioactive screening alternative
•    Enzyme-free detection technology
•    Compatible with any substrate

Applications
•    Kinases and ATPases
•    High Throughput Screening
•    Profiling
•    Mechanistic studies

Product HTRF® Transcreener® ADP
Company Cisbio Bioassays
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Cisbio Bioassays
Parc Marcel Boiteux BP 84175 30200 Codolet, France

Tel: +33 (0)4 66 79 67 05
Fax: +33 (0)4 66 79 19 20
Email: bioassays@cisbio.com



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!